Eagle Pharmaceuticals, Inc.
EGRX
Revenue
64.65M
▼-1.66M▼-2.50%
3 Months ChangeAssets
404.82M
▼-9.35M▼-2.26%
3 Months ChangeLiabilities
152.78M
▼-18.55M▼-10.83%
3 Months ChangeFree Cash Flow
-33.57M
▼-16.79M▼-100.07%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 8-K
ID: 0001104659-24-112887
2024-10-02
Form 8-K
ID: 0001104659-24-105232
2024-08-27
Form 8-K
ID: 0001104659-24-093448
2024-08-05
Form 8-K
ID: 0001104659-24-085668
2024-07-10
Form 8-K
ID: 0001104659-24-078777
2024-05-29
Form 8-K
ID: 0001104659-24-065884
2024-05-22
Form 8-K
ID: 0001104659-24-064099
2024-05-15
Form 8-K
ID: 0001104659-24-061683
2024-04-12
Form 8-K
ID: 0001104659-24-046776
2024-03-08
Form 8-K
ID: 0001104659-24-032458